Search All News
Amyloid sparks an alliance between two proteins in the brain that can potentially explain up to half of the gene changes that occur in Alzheimer’s.
A new study, led by George Mentis, Associate Professor of Pathology and Cell biology (in Neurology), has identified neurons that control mammalian locomotor behavior.
A new idea for treating Alzheimer’s disease could eradicate the toxic proteins most closely linked to cognitive decline in the places where they do the most damage.
Researchers at Columbia University Irving Medical Center have developed eye drops that could prevent vision loss after retinal vein occlusion.
- November 22, 2017
Dr. Carol Mason has been chosen as the 2017 Mika Salpeter Lifetime Achievement Award recipient.